Literature DB >> 18450427

Stability of visual masking performance in recent-onset schizophrenia: an 18-month longitudinal study.

Junghee Lee1, Keith H Nuechterlein, Kenneth L Subotnik, Catherine A Sugar, Joseph Ventura, Denise Gretchen-Doorly, Kimberly Kelly, Michael F Green.   

Abstract

Visual masking deficit in schizophrenia has been suggested to be a potential vulnerability marker for schizophrenia. An important characteristic of a vulnerability marker is stability over time, but relatively little is known about the longitudinal course of masking performance of schizophrenia patients. In this study, we examined the stability of visual masking performance in recent-onset schizophrenia patients over an 18-month period. We administered both forward and backward masking trials with multiple stimulus onset asynchronies for four masking conditions at three time points (baseline, 6-month, and 18-month). Recent-onset schizophrenia patients showed stable masking performance for both forward and backward conditions over a period of 18 months. Furthermore, the stable performance was observed across all four masking conditions. The findings of this study provide further support for the view that visual masking deficits reflect a possible vulnerability marker for schizophrenia.

Entities:  

Mesh:

Year:  2008        PMID: 18450427      PMCID: PMC2859819          DOI: 10.1016/j.schres.2008.03.005

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  35 in total

1.  The magnocellular visual system and schizophrenia: what can the color red tell us?

Authors:  Jeffrey S Bedwell; James M Brown; L Stephen Miller
Journal:  Schizophr Res       Date:  2003-10-01       Impact factor: 4.939

2.  Backward masking spatial frequency effects among hypothetically schizotypal individuals.

Authors:  R D Merritt; D W Balogh
Journal:  Schizophr Bull       Date:  1989       Impact factor: 9.306

Review 3.  Information processing in the primate visual system: an integrated systems perspective.

Authors:  D C Van Essen; C H Anderson; D J Felleman
Journal:  Science       Date:  1992-01-24       Impact factor: 47.728

4.  Backward-masking performance in chronic and nonchronic schizophrenics, affectively disturbed patients, and normal control subjects.

Authors:  B R Rund
Journal:  J Abnorm Psychol       Date:  1993-02

Review 5.  Information-processing abnormalities as neuropsychological vulnerability indicators for schizophrenia.

Authors:  K H Nuechterlein; M E Dawson; M F Green
Journal:  Acta Psychiatr Scand Suppl       Date:  1994

6.  Paracontrast and metacontrast in schizophrenia: clarifying the mechanism for visual masking deficits.

Authors:  Yuri Rassovsky; Michael F Green; Keith H Nuechterlein; Bruno Breitmeyer; Jim Mintz
Journal:  Schizophr Res       Date:  2004-12-01       Impact factor: 4.939

7.  Stability in backward masking performance in schizophrenics, affectively disturbed patients, and normal subjects.

Authors:  B R Rund; N I Landrø; A L Orbeck
Journal:  J Nerv Ment Dis       Date:  1993-04       Impact factor: 2.254

8.  Visual masking as a probe for abnormal gamma range activity in schizophrenia.

Authors:  Michael Foster Green; Jim Mintz; Dustin Salveson; Keith H Nuechterlein; Bruno Breitmeyer; Gregory A Light; David L Braff
Journal:  Biol Psychiatry       Date:  2003-06-15       Impact factor: 13.382

9.  Magnocellular and parvocellular contributions to backward masking dysfunction in schizophrenia.

Authors:  Isaac Schechter; Pamela D Butler; Gail Silipo; Vance Zemon; Daniel C Javitt
Journal:  Schizophr Res       Date:  2003-11-15       Impact factor: 4.939

10.  Developmental Processes in Schizophrenic Disorders: longitudinal studies of vulnerability and stress.

Authors:  K H Nuechterlein; M E Dawson; M Gitlin; J Ventura; M J Goldstein; K S Snyder; C M Yee; J Mintz
Journal:  Schizophr Bull       Date:  1992       Impact factor: 9.306

View more
  8 in total

1.  Fragile early visual percepts mark genetic liability specific to schizophrenia.

Authors:  Scott R Sponheim; Sarah M Sass; Althea L Noukki; Bridget M Hegeman
Journal:  Schizophr Bull       Date:  2012-03-23       Impact factor: 9.306

2.  From perception to functional outcome in schizophrenia: modeling the role of ability and motivation.

Authors:  Michael F Green; Gerhard Hellemann; William P Horan; Junghee Lee; Jonathan K Wynn
Journal:  Arch Gen Psychiatry       Date:  2012-12

3.  Visual information processing dysfunction across the developmental course of early psychosis.

Authors:  V B Perez; K M Shafer; K S Cadenhead
Journal:  Psychol Med       Date:  2012-04-03       Impact factor: 7.723

4.  Regional brain activity during early visual perception in unaffected siblings of schizophrenia patients.

Authors:  Junghee Lee; Mark S Cohen; Stephen A Engel; David Glahn; Keith H Nuechterlein; Jonathan K Wynn; Michael F Green
Journal:  Biol Psychiatry       Date:  2010-05-21       Impact factor: 13.382

5.  The shine-through masking paradigm is a potential endophenotype of schizophrenia.

Authors:  Eka Chkonia; Maya Roinishvili; Natia Makhatadze; Lidia Tsverava; Andrea Stroux; Konrad Neumann; Michael H Herzog; Andreas Brand
Journal:  PLoS One       Date:  2010-12-09       Impact factor: 3.240

6.  Association of the Nicotinic Receptor α7 Subunit Gene (CHRNA7) with Schizophrenia and Visual Backward Masking.

Authors:  George Bakanidze; Maya Roinishvili; Eka Chkonia; Werner Kitzrow; Sarina Richter; Konrad Neumann; Michael H Herzog; Andreas Brand; Imke Puls
Journal:  Front Psychiatry       Date:  2013-10-22       Impact factor: 4.157

Review 7.  Visual masking & schizophrenia.

Authors:  Michael H Herzog; Andreas Brand
Journal:  Schizophr Res Cogn       Date:  2015-05-08

8.  Early Visual Processing Is Associated With Social Cognitive Performance in Recent-Onset Schizophrenia.

Authors:  Amanda McCleery; Jonathan K Wynn; Junghee Lee; Eric A Reavis; Joseph Ventura; Kenneth L Subotnik; Michael F Green; Keith H Nuechterlein
Journal:  Front Psychiatry       Date:  2020-08-25       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.